Aggressive prostate cancer with somatic loss of the homologous recombination repair gene FANCA: a case report
Abstract Background Precision medicine based on genomic analysis of germline or tumor tissue is attracting attention. However, there is no consensus on how to apply the results of genomic analysis to treatment. Case presentation A 59-year-old man diagnosed with metastatic prostate cancer was diagnos...
Main Authors: | Hiroshi Hongo, Takeo Kosaka, Eriko Aimono, Hiroshi Nishihara, Mototsugu Oya |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Diagnostic Pathology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13000-019-0916-z |
Similar Items
-
Stitching up broken DNA ends by FANCA
by: Anna Palovcak, et al.
Published: (2018-11-01) -
The prevalence of gene mutations in homologous recombination repair pathways in Japanese patients with metastatic castration‐resistant prostate cancer in real‐world clinical practice: The multi‐institutional observational ZENSHIN study
by: Hiroji Uemura, et al.
Published: (2023-03-01) -
FANCA Polymorphism Is Associated with the Rate of Proliferation in Uterine Leiomyoma in Korea
by: Eunyoung Ha, et al.
Published: (2020-11-01) -
Next-Generation Sequencing Reveals a Very Low Prevalence of Deleterious Mutations of Homologous Recombination Repair Genes and Homologous Recombination Deficiency in Ovarian Clear Cell Carcinoma
by: Hangqi Liu, et al.
Published: (2022-01-01) -
Homologous Recombination Deficiency Scar: Mutations and Beyond—Implications for Precision Oncology
by: Alexander M. A. van der Wiel, et al.
Published: (2022-08-01)